Cardiovascular Sciences Inc. announced that it is entering into the next phase of development with its partnership with MedTech Enterprises. Cardiovascular Sciences Inc. is a client company of the award-winning University of Central Florida's Technology Incubator program. MedTech Enterprises is the company's division readying to spring forth with a retail internet program to market a premium antioxidant, anti-aging nutritional supplement. Over the past six weeks, the company has arranged for the production of a premium antioxidant supplement containing nutrients scientifically proven to reduce cholesterol levels which may reduce the risk of heart disease when taken with a diet low in saturated fats and cholesterol. The production of the product is nearing completion and a label for the Company's Cell Renewal Formula has cleared the regulatory compliance hurdle. The product is scheduled for release later.

Cardiovascular Sciences Inc. announced that the company has reached an operating agreement with Med. Tech. Enterprises Inc. Under this agreement, Cardiovascular Sciences Inc. will immediately assume all daily operations of Med. Tech. Enterprises Inc. Under this agreement, earnings will accrue to the benefit of Cardiovascular Sciences Inc.